These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12821619)

  • 1. The cost of major comorbidity in people with diabetes mellitus.
    Simpson SH; Corabian P; Jacobs P; Johnson JA
    CMAJ; 2003 Jun; 168(13):1661-7. PubMed ID: 12821619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care utilization and costs in Saskatchewan's registered Indian population with diabetes.
    Pohar SL; Johnson JA
    BMC Health Serv Res; 2007 Aug; 7():126. PubMed ID: 17697326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.
    Pohar SL; Majumdar SR; Johnson JA
    Clin Ther; 2007 Jun; 29(6 Pt 1):1316-24. PubMed ID: 18036393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.
    Pohar SL; Majumdar SR; Johnson JA
    Clin Ther; 2007; 29 Spec No():1316-24. PubMed ID: 18046931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Diabetes Self-Management Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost.
    Turner RM; Ma Q; Lorig K; Greenberg J; DeVries AR
    J Med Internet Res; 2018 Jun; 20(6):e207. PubMed ID: 29934284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
    Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization.
    Struijs JN; Baan CA; Schellevis FG; Westert GP; van den Bos GA
    BMC Health Serv Res; 2006 Jul; 6():84. PubMed ID: 16820048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities.
    Candrilli SD; Meyers JL; Boye K; Bae JP
    J Diabetes Complications; 2015; 29(4):529-33. PubMed ID: 25660136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive performance of comorbidity measures in administrative databases for diabetes cohorts.
    Lix LM; Quail J; Fadahunsi O; Teare GF
    BMC Health Serv Res; 2013 Aug; 13():340. PubMed ID: 24059446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental Healthcare Resource Utilization and Expenditures Associated with Cardiovascular Diseases in Patients with Diabetes: A Cross-Sectional Study.
    Ebrahimoghli R; Janati A; Sadeghi-Bazargani H; Hamishehkar H; Khalili-Azimi A
    Iran J Med Sci; 2022 Jan; 47(1):53-62. PubMed ID: 35017778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care expenditures for people with diabetes mellitus, 1992.
    Rubin RJ; Altman WM; Mendelson DN
    J Clin Endocrinol Metab; 1994 Apr; 78(4):809A-809F. PubMed ID: 8157701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.